TY  - GEN
AU  - Devesa, Ana
AU  - Lobo-González, Manuel
AU  - Martínez-Milla, Juan
AU  - Oliva, Belén
AU  - García-Lunar, Inés
AU  - Mastrangelo, Annalaura
AU  - España, Samuel
AU  - Sanz, Javier
AU  - Mendiguren, José M
AU  - Bueno, Hector
AU  - Fuster Salva, Jose
AU  - Andres, Vicente
AU  - Fernandez-Ortiz, Antonio
AU  - Sancho, David
AU  - Fernandez-Friera, Leticia
AU  - Sánchez-González, Javier
AU  - Rosselló, Xavier
AU  - Ibanez, Borja
AU  - Fuster, Valentin
AU  - Devesa, Ana
AU  - Lobo-González, Manuel
AU  - Martínez-Milla, Juan
AU  - Oliva, Belén
AU  - García-Lunar, Inés
AU  - Mastrangelo, Annalaura
AU  - España, Samuel
AU  - Sanz, Javier
AU  - Mendiguren, José M
AU  - Bueno, Hector
AU  - Fuster Salva, Jose
AU  - Andres, Vicente
AU  - Fernandez-Ortiz, Antonio
AU  - Sancho, David
AU  - Fernandez-Friera, Leticia
AU  - Sánchez-González, Javier
AU  - Rosselló, Xavier
AU  - Ibanez, Borja
AU  - Fuster, Valentin
PY  - 2022
DO  - 10.1093/eurheartj/ehac102
UR  - https://hdl.handle.net/20.500.12105/23393
AB  - Aims: Experimental studies suggest that increased bone marrow (BM) activity is involved in the association between cardiovascular risk factors and inflammation in atherosclerosis. However, human data to support this association are sparse. The purpose...
LA  - eng
KW  - Bone marrow
KW  - Metabolic syndrome
KW  - PET/MRI
KW  - Subclinical atherosclerosis
KW  - Metabolic Syndrome
KW  - Radiopharmaceuticals
KW  - Bone Marrow
KW  - Positron-Emission Tomography
KW  - Humans
KW  - Inflammation
KW  - Middle Aged
KW  - Plaque, Atherosclerotic
KW  - Male
KW  - Biomarkers
KW  - Positron Emission Tomography Computed Tomography
KW  - Female
KW  - Atherosclerosis
KW  - Fluorodeoxyglucose F18
TI  - Bone marrow activation in response to metabolic syndrome and early atherosclerosis
TY  - research article
ER  -